SPTX

Seaport Therapeutics, Inc.

Healthcare · Biotechnology

20.20$ +7.9% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Income Statement

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement SPTX
Line item	2024	2025
Revenue	0.00	0.00
Research & Development	0.47	1.72
Selling, General & Administrative	0.52	0.54
Total Operating Expenses	0.99	2.26
Operating Income	-0.99	-2.26
Pre-Tax Income	-0.88	-1.92
Income Tax Expense	–	0.02
Net Income	-0.88	-1.94
EBITDA	–	-2.22

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.